• Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 20 Jan 2025 03:51:17   America/Chicago


    Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 20, 2025 Share Link copied to clipboard. Akero Therapeutics, Inc. ( NASDAQ:AKRO - Get Free Report ) has b
    Read more...
Share on,